When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

People with ADHD often struggle with executive function, which Didier describes as “your brain’s GPS” for navigating your day ...

Many with ADHD grieve a life they feel they’ve missed. Healing begins by naming it—and choosing a new way forward.

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

Figures suggest adults with ADHD are five times more likely to try to take their own lives than those without it. | ITV News ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...